AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 33%
#1641 out of 5077 analysts
Average Return
+22.02%
Win Rate
70%7 out of 10
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sagimet Biosciences IncSGMT | +97.84% | $4.62 | $9.14 | 2025-01-27 - 2025-10-24 | Strong Buy |
Sionna Therapeutics IncSION | +81.36% | $21.62 | $39.21 | 2025-09-08 - 2025-10-24 | Strong Buy |
Sagimet Biosciences IncSGMT | +64.39% | $5.56 | $9.14 | 2025-06-06 - 2025-10-24 | Strong Buy |
Contineum Therapeutics IncCTNM | +54.76% | $7.14 | $11.05 | 2025-03-13 - 2025-10-24 | Strong Buy |
Theravance Biopharma IncTBPH | +34.72% | $10.60 | $14.28 | 2025-06-17 - 2025-10-24 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sionna Therapeutics IncSION | 1 | Strong Buy | $46.00 | +17.32% | Initiates Coverage On | 2 months ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | +68.07% | Initiates Coverage On | 4 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | +195.40% | Maintains | 5 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +684.71% | Initiates Coverage On | 6 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | +169.54% | Maintains | 7 months ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | +108.14% | Initiates Coverage On | 7 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.